{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:57:10Z","timestamp":1793761030622,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001377","name":"Walther Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE1313583"],"award-info":[{"award-number":["DGE1313583"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17SDG33680177"],"award-info":[{"award-number":["17SDG33680177"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA109545"],"award-info":[{"award-number":["RO1CA109545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000969","name":"American Institute for Cancer Research","doi-asserted-by":"publisher","award":["579937"],"award-info":[{"award-number":["579937"]}],"id":[{"id":"10.13039\/100000969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epithelial ovarian cancer (EOC) metastasis occurs by exfoliation of cells and multicellular aggregates (MCAs) from the tumor into the peritoneal cavity, adhesion to and retraction of peritoneal mesothelial cells and subsequent anchoring. Elevated levels of lysophosphatidic acid (LPA) have been linked to aberrant cell proliferation, oncogenesis, and metastasis. LPA disrupts junctional integrity and epithelial cohesion in vitro however, the fate of free-floating cells\/MCAs and the response of host peritoneal tissues to LPA remain unclear. EOC MCAs displayed significant LPA-induced changes in surface ultrastructure with the loss of cell surface protrusions and poor aggregation, resulting in increased dissemination of small clusters compared to untreated control MCAs. LPA also diminished the adhesive capacity of EOC single cells and MCAs to murine peritoneal explants and impaired MCA survival and mesothelial clearance competence. Peritoneal tissues from healthy mice injected with LPA exhibited enhanced mesothelial surface microvilli. Ultrastructural alterations were associated with restricted peritoneal susceptibility to metastatic colonization by single cells as well as epithelial-type MCAs. The functional consequence is an LPA-induced dissemination of small mesenchymal-type clusters, promoting a miliary mode of peritoneal seeding that complicates surgical removal and is associated with worse prognosis.<\/jats:p>","DOI":"10.1038\/s41598-020-67565-7","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T10:26:17Z","timestamp":1593685577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination"],"prefix":"10.1038","volume":"10","author":[{"given":"Yuliya","family":"Klymenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sharon","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"67565_CR1","unstructured":"American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society (accessed 13 April 2020); https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2018.html (2018)."},{"key":"67565_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Ahmedin, J. Cancer statistics, 2018. CA Cancer J Clin 68, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"CA Cancer J Clin"},{"key":"67565_CR3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"F Jacques","year":"2015","unstructured":"Jacques, F. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int. J. Cancer"},{"key":"67565_CR4","unstructured":"Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J., Cronin, K.A. (eds). SEER Cancer Statistics Review, 1975\u20132011. National Cancer Institute, Bethesda, MD. Based on November 2013 SEER data submission, posted to the SEER web site, April 2014 (accessed 13 April 2020); https:\/\/seer.cancer.gov\/csr\/1975_2011\/."},{"key":"67565_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/jca.7810","volume":"5","author":"CS Marcus","year":"2014","unstructured":"Marcus, C. S., Maxwell, G. L., Darcy, K. M., Hamilton, C. A. & McGuire, W. P. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J. Cancer 5, 25. https:\/\/doi.org\/10.7150\/jca.7810 (2014).","journal-title":"J. Cancer"},{"key":"67565_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053\u20131064. https:\/\/doi.org\/10.2353\/ajpath.2010.100105 (2010).","journal-title":"Am. J. Pathol."},{"key":"67565_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cancers9080104","volume":"9","author":"Y Klymenko","year":"2017","unstructured":"Klymenko, Y., Kim, O. & Stack, M. S. Complex determinants of epithelial: Mesenchymal phenotypic plasticity in ovarian cancer. Cancers 9, 104. https:\/\/doi.org\/10.3390\/cancers9080104 (2017).","journal-title":"Cancers"},{"key":"67565_CR8","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","volume":"37","author":"S Al Habyan","year":"2018","unstructured":"Al Habyan, S., Kalos, C., Szymborski, J. & McCaffrey, L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene 37, 5127. https:\/\/doi.org\/10.1038\/s41388-018-0317-x (2018).","journal-title":"Oncogene"},{"key":"67565_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000163419","volume":"55","author":"H Allen","year":"1987","unstructured":"Allen, H., Porter, C., Gamarra, M., Piver, M. & Johnson, E. Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Pathobiology 55, 194\u2013208. https:\/\/doi.org\/10.1159\/000163419 (1987).","journal-title":"Pathobiology"},{"key":"67565_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","volume":"93","author":"KM Burleson","year":"2004","unstructured":"Burleson, K. M. et al. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol. Oncol. 93, 170\u2013181. https:\/\/doi.org\/10.1016\/j.ygyno.2003.12.034 (2004).","journal-title":"Gynecol. Oncol."},{"key":"67565_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","volume":"113","author":"K Shield","year":"2009","unstructured":"Shield, K., Ackland, M. L., Ahmed, N. & Rice, G. E. Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol. Oncol. 113, 143\u2013148. https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.032 (2009).","journal-title":"Gynecol. Oncol."},{"key":"67565_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F. & Correia, I. J. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol. Bioeng. 116, 206\u2013226. https:\/\/doi.org\/10.1002\/bit.26845 (2019).","journal-title":"Biotechnol. Bioeng."},{"key":"67565_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/labinvest.2013.41","volume":"93","author":"JM Lee","year":"2013","unstructured":"Lee, J. M. et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab. Invest. 93, 528\u2013542. https:\/\/doi.org\/10.1038\/labinvest.2013.41 (2013).","journal-title":"Lab. Invest."},{"key":"67565_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1040-8428(00)00077-9","volume":"36","author":"RC Bates","year":"2000","unstructured":"Bates, R. C., Edwards, N. S. & Yates, J. D. Spheroids and cell survival. Crit. Rev. Oncol. 36, 61\u201374. https:\/\/doi.org\/10.1016\/s1040-8428(00)00077-9 (2000).","journal-title":"Crit. Rev. Oncol."},{"key":"67565_CR15","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1038\/oncsis.2017.77","volume":"6","author":"N Woolf","year":"2017","unstructured":"Woolf, N. et al. Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy. Oncogenesis 6, e378. https:\/\/doi.org\/10.1038\/oncsis.2017.77 (2017).","journal-title":"Oncogenesis"},{"key":"67565_CR16","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin, M. et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J. Clin. Invest. 126, 4157\u20134173. https:\/\/doi.org\/10.1172\/JCI87252 (2016).","journal-title":"J. Clin. Invest."},{"key":"67565_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.118526","author":"S Azadi","year":"2019","unstructured":"Azadi, S. et al. Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions. Biochim. Biophys. Acta BBA Mol. Cell. Res. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.118526 (2019).","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell. Res."},{"key":"67565_CR18","doi-asserted-by":"publisher","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","volume":"9","author":"J Liao","year":"2014","unstructured":"Liao, J. et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS ONE 9, e84941. https:\/\/doi.org\/10.1371\/journal.pone.0084941 (2014).","journal-title":"PLoS ONE"},{"key":"67565_CR19","doi-asserted-by":"publisher","first-page":"29845","DOI":"10.1016\/j.canlet.2014.11.055","volume":"9","author":"Y Miyatake","year":"2018","unstructured":"Miyatake, Y., Ohta, Y., Ikeshita, S. & Kasahara, M. Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells. Oncotarget 9, 29845. https:\/\/doi.org\/10.1016\/j.canlet.2014.11.055 (2018).","journal-title":"Oncotarget"},{"key":"67565_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.canlet.2014.11.055","volume":"357","author":"Y Miyatake","year":"2015","unstructured":"Miyatake, Y., Sheehy, N., Ikeshita, S., Hall, W. W. & Kasahara, M. Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like ATL cells in an NF-\u03baB-and vimentin-dependent manner. Cancer Lett. 357, 355\u2013363 (2015).","journal-title":"Cancer Lett."},{"key":"67565_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/onc.2017.171","volume":"1","author":"Y Klymenko","year":"2017","unstructured":"Klymenko, Y. et al. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis. Oncogene 1, 12. https:\/\/doi.org\/10.1038\/onc.2017.171 (2017).","journal-title":"Oncogene"},{"key":"67565_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.014","author":"CF Labuschagne","year":"2019","unstructured":"Labuschagne, C. F., Cheung, E. C., Blagih, J., Domart, M. & Vousden, K. H. Cell clustering promotes a metabolic switch that supports metastatic colonization. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2019.07.014 (2019).","journal-title":"Cell Metab."},{"key":"67565_CR23","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/s0002-9440(10)63058-1","volume":"159","author":"RC Casey","year":"2001","unstructured":"Casey, R. C. et al. \u03b21-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am. J. Pathol. 159, 2071\u20132080. https:\/\/doi.org\/10.1016\/s0002-9440(10)63058-1 (2001).","journal-title":"Am. J. Pathol."},{"key":"67565_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neo.2017.04.002","volume":"19","author":"Y Klymenko","year":"2017","unstructured":"Klymenko, Y. et al. Heterogeneous cadherin expression and multicellular aggregate dynamics in ovarian cancer dissemination. Neoplasia 19, 549\u2013563. https:\/\/doi.org\/10.1016\/j.neo.2017.04.002 (2017).","journal-title":"Neoplasia"},{"key":"67565_CR25","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.22034\/APJCP.2018.19.9.2493","volume":"19","author":"L Gong","year":"2018","unstructured":"Gong, L., Zheng, Y., Liu, S. & Peng, Z. Fibronectin regulates the dynamic formation of ovarian cancer multicellular aggregates and the expression of integrin receptors. Asian Pac. J. Cancer. Prev. 19, 2493\u20132498. https:\/\/doi.org\/10.22034\/APJCP.2018.19.9.2493 (2018).","journal-title":"Asian Pac. J. Cancer. Prev."},{"key":"67565_CR26","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1074\/jbc.M117.800904","volume":"292","author":"J Yang","year":"2017","unstructured":"Yang, J. et al. Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics. J. Biol. Chem. 292, 13111\u201313121. https:\/\/doi.org\/10.1074\/jbc.M117.800904 (2017).","journal-title":"J. Biol. Chem."},{"key":"67565_CR27","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1158\/1541-7786.MCR-18-1205","volume":"17","author":"JS Suarez","year":"2019","unstructured":"Suarez, J. S. et al. CD44 regulates formation of spheroids and controls organ-specific metastatic colonization in epithelial ovarian carcinoma. Mol. Cancer Res. 17, 1801\u20131814. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1205 (2019).","journal-title":"Mol. Cancer Res."},{"key":"67565_CR28","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.7150\/jca.31329","volume":"10","author":"Y Sun","year":"2019","unstructured":"Sun, Y. et al. CDC25A facilitates chemo-resistance in ovarian cancer multicellular spheroids by promoting E-cadherin expression and arresting cell cycles. J. Cancer 10, 2874\u20132884. https:\/\/doi.org\/10.7150\/jca.31329 (2019).","journal-title":"J. Cancer"},{"key":"67565_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-019-1127-x","volume":"38","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress. J. Exp. Clin. Cancer Res. 38, 116. https:\/\/doi.org\/10.1186\/s13046-019-1127-x (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"67565_CR30","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.18632\/oncotarget.14206","volume":"8","author":"KL Boylan","year":"2017","unstructured":"Boylan, K. L. et al. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget 8, 9717\u20139738. https:\/\/doi.org\/10.18632\/oncotarget.14206 (2017).","journal-title":"Oncotarget"},{"key":"67565_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc1143","volume":"3","author":"GB Mills","year":"2003","unstructured":"Mills, G. B. & Moolenaar, W. H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582\u2013591. https:\/\/doi.org\/10.1038\/nrc1143 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"67565_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-4757-3587-1_12","volume-title":"Ovarian Cancer","author":"GB Mills","year":"2002","unstructured":"Mills, G. B. et al. Ovarian Cancer 259\u2013283 (Springer, New York, 2002). https:\/\/doi.org\/10.1007\/978-1-4757-3587-1_12"},{"key":"#cr-split#-67565_CR33.1","doi-asserted-by":"crossref","unstructured":"Sutphen, R. et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 13, 1185-1191 (accessed 13 April 2020)","DOI":"10.1158\/1055-9965.1185.13.7"},{"key":"#cr-split#-67565_CR33.2","unstructured":"https:\/\/cebp.aacrjournals.org\/content\/13\/7\/1185.long (2004)."},{"key":"67565_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung, Y. C., Stoddard, N. C. & Chun, J. LPA receptor signaling: Pharmacology, physiology, and pathophysiology. J. Lipid Res. 55, 1192\u20131214. https:\/\/doi.org\/10.1194\/jlr.R046458 (2014).","journal-title":"J. Lipid Res."},{"key":"67565_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/abio.2001.5000","volume":"290","author":"Y Xiao","year":"2001","unstructured":"Xiao, Y. et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem. 290, 302\u2013313. https:\/\/doi.org\/10.1006\/abio.2001.5000 (2001).","journal-title":"Anal. Biochem."},{"key":"67565_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/a:1008217129273","volume":"9","author":"AM Westermann","year":"1998","unstructured":"Westermann, A. M. et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann. Oncol. 9, 437\u2013442. https:\/\/doi.org\/10.1023\/a:1008217129273 (1998).","journal-title":"Ann. Oncol."},{"key":"67565_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/1878-0261.12396","volume":"13","author":"S Reinartz","year":"2019","unstructured":"Reinartz, S. et al. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment. Mol. Oncol. 13, 185\u2013201. https:\/\/doi.org\/10.1002\/1878-0261.12396 (2019).","journal-title":"Mol. Oncol."},{"key":"#cr-split#-67565_CR38.1","unstructured":"Eder, A. M., Sasagawa, T., Mao, M., Aoki, J. & Mills, G. B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2. Clin. Cancer Res. 6, 2482-2491 (accessed 13 April 2020)"},{"key":"#cr-split#-67565_CR38.2","unstructured":"https:\/\/clincancerres.aacrjournals.org\/content\/6\/6\/2482.long (2000)."},{"key":"67565_CR39","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","volume":"66","author":"J Ren","year":"2006","unstructured":"Ren, J. et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 66, 3006\u20133014. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1292 (2006).","journal-title":"Cancer Res."},{"key":"67565_CR40","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1158\/1535-7163.MCT-08-1106","volume":"8","author":"H Li","year":"2009","unstructured":"Li, H. et al. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis\/metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer. Ther. 8, 1692\u20131701. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-1106 (2009).","journal-title":"Mol. Cancer. Ther."},{"key":"67565_CR41","doi-asserted-by":"publisher","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","volume":"66","author":"KS Kim","year":"2006","unstructured":"Kim, K. S. et al. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 66, 7983\u20137990. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4381 (2006).","journal-title":"Cancer Res."},{"key":"67565_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/stem.2279","volume":"34","author":"EJ Seo","year":"2016","unstructured":"Seo, E. J. et al. Autotaxin regulates maintenance of ovarian cancer stem cells through lysophosphatidic acid-mediated autocrine mechanism. Stem Cells 34, 551\u2013564. https:\/\/doi.org\/10.1002\/stem.2279 (2016).","journal-title":"Stem Cells"},{"key":"67565_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/501492","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells. J. Oncol. https:\/\/doi.org\/10.1155\/2012\/501492 (2012).","journal-title":"J. Oncol."},{"key":"67565_CR44","doi-asserted-by":"publisher","first-page":"15295","DOI":"10.1038\/s41598-017-15547-7","volume":"7","author":"KA Bailey","year":"2017","unstructured":"Bailey, K. A. et al. Chemical analysis of morphological changes in lysophosphatidic acid-treated ovarian cancer cells. Sci. Rep. 7, 15295. https:\/\/doi.org\/10.1038\/s41598-017-15547-7 (2017).","journal-title":"Sci. Rep."},{"key":"#cr-split#-67565_CR45.1","unstructured":"Kiyasu, Y., Kaneshima, S. & Koga, S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res. 41, 1236-1239 (accessed 13 April 2020)"},{"key":"#cr-split#-67565_CR45.2","unstructured":"https:\/\/cancerres.aacrjournals.org\/content\/41\/3\/1236.long (1981)."},{"key":"#cr-split#-67565_CR46.1","unstructured":"Birbeck, M. S. & Wheatley, D. N. An electron microscopic study of the invasion of ascites tumor cells into the abdominal wall. Cancer Res. 25, 490-497 (accessed 13 April 2020)"},{"key":"#cr-split#-67565_CR46.2","unstructured":"https:\/\/cancerres.aacrjournals.org\/content\/25\/4_Part_1\/490 (1965)."},{"key":"67565_CR47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.280.8.719","volume":"280","author":"Y Xu","year":"1998","unstructured":"Xu, Y. et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280, 719\u2013723. https:\/\/doi.org\/10.1001\/jama.280.8.719 (1998).","journal-title":"JAMA"},{"key":"67565_CR48","doi-asserted-by":"publisher","first-page":"22143","DOI":"10.1074\/jbc.M115.641092","volume":"290","author":"RJ Burkhalter","year":"2015","unstructured":"Burkhalter, R. J., Westfall, S. D., Liu, Y. & Stack, M. S. lysophosphatidic acid initiates epithelial to mesenchymal transition and induces beta-catenin-mediated transcription in epithelial ovarian carcinoma. J. Biol. Chem. 290, 22143\u201322154. https:\/\/doi.org\/10.1074\/jbc.M115.641092 (2015).","journal-title":"J. Biol. Chem."},{"key":"67565_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ygyno.2017.09.021","volume":"147","author":"D Torres","year":"2017","unstructured":"Torres, D. et al. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer. Gynecol. Oncol. 147, 503\u2013508. https:\/\/doi.org\/10.1016\/j.ygyno.2017.09.021 (2017).","journal-title":"Gynecol. Oncol."},{"key":"67565_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1526-3","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban, V. et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature https:\/\/doi.org\/10.1038\/s41586-019-1526-3 (2019).","journal-title":"Nature"},{"key":"67565_CR51","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1172\/JCI69815","volume":"124","author":"RA Davidowitz","year":"2014","unstructured":"Davidowitz, R. A. et al. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J. Clin. Invest. 124, 2611\u20132625. https:\/\/doi.org\/10.1172\/JCI69815 (2014).","journal-title":"J. Clin. Invest."},{"key":"67565_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bit.10655","volume":"83","author":"JM Kelm","year":"2003","unstructured":"Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M. & Nielsen, L. K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol. Bioeng. 83, 173\u2013180. https:\/\/doi.org\/10.1002\/bit.10655 (2003).","journal-title":"Biotechnol. Bioeng."},{"key":"67565_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"L-B Weiswald","year":"2015","unstructured":"Weiswald, L.-B., Bellet, D. & Dangles-Marie, V. Spherical cancer models in tumor biology. Neoplasia 17, 1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004 (2015).","journal-title":"Neoplasia"},{"key":"67565_CR54","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel, E. et al. Epithelial ovarian cancer experimental models. Oncogene 33, 3619\u20133633. https:\/\/doi.org\/10.1038\/onc.2013.321 (2014).","journal-title":"Oncogene"},{"key":"67565_CR55","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1515\/hsz-2014-0155","volume":"395","author":"L Bruney","year":"2014","unstructured":"Bruney, L., Conley, K. C., Moss, N. M., Liu, Y. & Stack, M. S. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16\/CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium. Biol. Chem. 395, 1221\u20131231. https:\/\/doi.org\/10.1515\/hsz-2014-0155 (2014).","journal-title":"Biol. Chem."},{"key":"67565_CR56","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67565-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:32:37Z","timestamp":1670333557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67565-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67565-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10877"}}